FDA asks manufacturers to recall heartburn drugs over traces of possible carcinogen
The move comes six months after an online pharmacy that ran its own tests of the drugs petitioned the FDA to push for a full-blown recall.
The FDA has asked all manufacturers of a particular heartburn medicine known as ranitidine, sold under several brands including Zantac, to withdraw their drugs because “unacceptable levels” of a possible carcinogen may develop in the pills over time.
FDA asks manufacturers to recall heartburn drugs over traces of a possible carcinogen..
#pharma #heartburn #Zantac #carcinogen #cancer #NDMA